• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Breast Cancer-Basic and Clinical Research

    Breast Cancer-Basic and Clinical Research

    JournalISSN 1178-2234eISSN 1178-2234中科院 医学 4区

    年发文量

    研究主题

    论文(391)

    排序
    1Breast Cancer Incidence and Risk Factors among Active-Duty Members of the Armed Forces: A Report to Congress
    Lynette Hamlin PhD, RN, CNM, FACNM, FAAN, Rachel Gabor MS

    Background The incidence of breast cancer among active-duty service members remains a critical area of public health surveillance and research within the Armed Forces. Objectives This study was conducted in response to the National Defense Authorization Act (NDAA) for Fiscal Year 2022, Section 740, to determine the incidence of breast cancer among members of the Armed Forces serving on active duty between January 1, 2011 and October 31, 2022, and to compare these rates to the civilian population. Design A retrospective cohort study was designed to examine the incidence of breast cancer among active-duty service members and the demographic, military, and health characteristics associated with breast cancer among service members. Methods Data was obtained from the Epidemiology and Analysis Branch, Armed Forces Health Surveillance Division, Public Health Directorate of the Defense Health Agency. The sample total was 3,400,394 active members of the Armed Forces between Jan 1, 2011 and Oct 31, 2022. Results Among 570,612 active service women, there were 973 women diagnosed with breast cancer. This accounted for 0.2% of the female active military population. Compared to civilian women, there were 7.5 and 60.0 additional cases of breast cancer among 17-39- and 40–64-year-old ADSW, respectively. After adjustment for other risk factors, the estimated risk associated with burn pit exposure was greatly reduced and no longer significant (aRR: 1.05, 95% CI: 0.90-1.21). Conclusion This study confirms that active-duty service women continue to have higher breast cancer rates than the overall US population. Age, race, and family history of certain cancers were associated with increased risk of breast cancer among active-duty service women, but, with the exception of rank, characteristics of military service were not associated with risk of BC.

    2026
    引用
    AI阅读
    加入学术空间
    2Adipose-Derived Stem Cell–Enriched Fat Grafting for Breast Reconstruction: A Systematic Review of Efficacy and Oncological Safety
    Francesca Maria Scura MD,Elisa Bertulla MD,Edoardo Raposio MD, PhD, FICS

    Background Autologous fat grafting is increasingly used for breast reconstruction, but unpredictable resorption (retention 25–80%) limits its utility. Enrichment with adipose-derived stem cells (ADSCs) or the stromal vascular fraction (SVF), termed cell-assisted lipotransfer (CAL), has been proposed to improve graft survival. Objectives This systematic review evaluates the efficacy and oncological safety of ADSC/SVF-enriched fat grafting for breast reconstruction and augmentation. Design Systematic review without meta-analysis, reported in accordance with PRISMA 2020. Data Sources and Methods PubMed MEDLINE, Scopus and the Cochrane Library were searched combining terms for adipose-derived stem cells, stromal vascular fraction, cell-assisted lipotransfer, breast reconstruction, breast augmentation, fat grafting and lipofilling. English-language human studies were eligible; nineteen studies were included and analysed qualitatively. Results Nineteen studies (randomised trials, comparative cohorts and case series, 2007–2020) were included. A triple-blind RCT of ex vivo–expanded ADSCs showed retention of 80.9% versus 16.3% (p < 0.0001); a subsequent RCT reported 80.2% versus 45.1%. Pooled analyses confirmed a mean retention benefit of approximately 27%, with the largest gains for expanded ADSCs and more modest gains for SVF-based methods. One prospective study found no significant advantage of SVF enrichment (74% versus 79%). Complication rates were comparable between enriched and conventional grafts. No consistent increase in locoregional recurrence was observed, except in patients with intraepithelial neoplasia. Conclusion ADSC/SVF-enriched fat grafting can improve graft retention, with ex vivo–expanded ADSCs yielding the most consistent benefit. The evidence is heterogeneous; standardisation of cell-isolation methods, outcome reporting and long-term oncological surveillance is required before routine adoption.

    2026
    引用
    AI阅读
    加入学术空间
    3Stress Hormone-Induced Remodeling of the MMP/TIMP System in Breast Cancer Cells of Different Malignant Potential
    Nataliia Lukianova, Tetiana Burda,Oleksandr Mushii,Taras Zadvornyi, Anna Pavlova,Vasyl Chekhun

    Background Chronic stress may modify breast cancer progression through neuroendocrine regulation of tumor cell behavior and extracellular matrix remodeling. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are key components of proteolytic control associated with invasion and metastatic dissemination. Objectives To evaluate the effects of adrenaline and dexamethasone as model catecholaminergic and glucocorticoid stress-related factors on MMP and TIMP expression in human breast cancer cells with different malignant potential. Design Experimental in vitro study using two human breast cancer cell lines with different malignant potential. Methods MCF-7 and MDA-MB-231 cells were exposed to adrenaline or dexamethasone under previously validated chronic stress-modeling conditions. MMP and TIMP mRNA expression was assessed by qPCR, while protein expression was evaluated by immunocytochemistry using the H-score method. Results In MDA-MB-231 cells, adrenaline activated a broad MMP transcriptional response involving gelatinases and selected collagenases, whereas protein changes were mainly associated with collagenases. Dexamethasone enhanced gelatinase gene expression in these cells but increased protein levels predominantly within the collagenase and MMP-14, without significant changes in gelatinase protein expression. In MCF-7 cells, adrenaline mainly increased gelatinase and MMP14 transcripts, whereas protein-level changes involved increased MMP-9 and MMP-13 and reduced MMP-1 and MMP-8. Dexamethasone broadly reduced MMP transcript levels but increased several MMP proteins, including MMP-1, MMP-9, MMP-13, and MMP-14. Both hormones reduced TIMP-2 protein levels in both cell lines. In MDA-MB-231 cells, hormonal exposure induced TIMP3 /TIMP-3 expression, absent under control conditions, and reduced TIMP-4 protein levels. In MCF-7 cells, adrenaline increased TIMP3 transcript expression, whereas dexamethasone reduced TIMP3 /TIMP-3 expression and induced detectable TIMP-4 protein expression. Conclusion Adrenaline and dexamethasone exert distinct effects on the MMP/TIMP expression balance in breast cancer cells, indicating that stress-associated modulation of extracellular matrix remodeling is shaped by both the type of hormonal stimulus and tumor cell phenotype.

    2026
    引用
    AI阅读
    加入学术空间
    4Combination of Radiation Treatment and PLK4-Inhibitor, CFI-400945, Leads to Upregulation of ICAM-1, STAT3 Activation, and Cellular Senescence in TNBC
    Isabel Kannampuzha,Vasudeva Bhat, Sugitha Janarthanan, Harjot K. Athwal, Kaitlyn E. Wade,Pingzhao Hu,Alison L. Allan,Armen Parsyan

    Background Triple-negative breast cancer (TNBC) is one of the most aggressive and highly metastatic subtypes of breast cancer. It lacks canonical biomarkers and is often resistant to treatments, including radiotherapy (RT). This mandates the development of better treatments through identifying novel therapeutic targets and biomarkers in TNBC to improve patient stratification for treatment and facilitate novel drug development. We have previously shown that anticancer effects of RT are synergized by the inhibition of polo-like kinase 4 (PLK4) by CFI-400945. Objectives, Design and Methods In the present study, we aimed to obtain mechanistic insights of the anticancer effects of RT in combination with CFI-400945 using bulk RNA-sequencing in MDA-MB-231 TNBC cells treated with single agents and their combination. Results Differential gene expression (DEG) and pathway enrichment analyses of the bulk transcriptomics data have identified perturbations in immune and senescence related genes and pathways in TNBC cells treated with RT alone or in combination with CFI-400945. Validation of the identified DEGs showed significant upregulation of ICAM - 1 (Intercellular Adhesion Molecule-1) both at transcript and protein levels following combination treatment compared to untreated control cells. This was accompanied by activation of STAT3 protein and increased cellular senescence determined by β-galactosidase assay in combination treatment compared to untreated control. Conclusion Overall, our data suggest that ICAM-1 and STAT3 signaling axis may play an important role in TNBC cell response to RT and PLK4 inhibition.

    2026
    引用
    AI阅读
    加入学术空间
    5Impact of EXO1 (K589E) Genetic Variant on Breast Cancer Risk: Evidence from Bangladesh
    Md. Mahamudul Kabir, Md. Abdur Rahman, Sm Faysal Bellah,Md. Golam Hossain,Md. Mustafizur Rahman

    Background Exonuclease 1 ( EXO1 ) is a key nuclease in the DNA mismatch repair (MMR) pathway and is involved in correcting replication errors while maintaining genomic stability. The K589E (rs1047840) single nucleotide polymorphism (SNP) of EXO1 has been associated with cancer susceptibility in different populations. Objectives This study aimed to investigate the association between the EXO1 K589E polymorphism and breast cancer risk, as well as its relationship with selected clinicopathological characteristics in Bangladeshi women. Design Hospital-based case-control study. Methods The present case–control study included 184 patients with histologically confirmed breast cancer and 200 age-matched cancer-free controls. Genotyping of the EXO1 K589E variant was carried out using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis and subsequently confirmed by direct sequencing. The associations between the polymorphism and breast cancer risk were assessed using logistic regression, with odds ratios (ORs) and corresponding 95% confidence intervals (CIs) calculated. Results The frequencies of G/G, G/A, and A/A genotypes were 49.5, 41.8, and 8.7% among cases, compared with 69, 27.5, and 3.5% among controls, respectively. Both the heterozygous (G/A) and homozygous variant (A/A) genotypes were significantly associated with elevated breast cancer risk (OR= 2.12, 95% CI= 1.37-3.28, p = 0.0007; OR= 3.46, 95 % CI= 1.37-8.76, p = 0.0086, respectively). The combined variant genotypes (G/A + A/A) conferred a 2.27-fold higher risk ( p = 0.0001), and the A allele was also strongly associated with breast cancer predisposition (OR= 2.01, 95% CI= 1.43-2.84, p = 0.0001). The association remained significant under codominant, dominant, recessive, overdominant, and log-additive genetic models. Significant correlations were observed between the variant genotype and menopausal status, body mass index (BMI), and tumor stage. Conclusion The results indicate that the EXO1 K589E polymorphism is significantly associated with an increased risk of breast cancer in Bangladeshi women and may also be related to key clinicopathological features of the disease.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 391 篇论文

    高被引作者

    作者引用发文
    Hicks David G6784
    Ping Tang6773
    Thomas A. Bonfiglio5602
    Lianping Xing5591
    Tamera Strzepek5591
    Kristina Subik5591
    Mien-Chie Hung5591
    Abdelraouf Kamilia3491
    Nada Ahmed3491
    Nounou Mohamed I3491

    高产作者

    作者引用发文
    Aoife Lowery1116
    Mia K. Markey615
    Summer Acevedo1204
    Michelle Fingeret564
    Elisabeth K. Beahm564
    Fatima A. Merchant564
    Gregory P. Reece564
    Amy M. Fulton774
    Hicks David G6784
    Matthew G. Davey183

    相关期刊

    Breast Cancer
    Clinical Breast Cancer
    Breast cancer : basic and clinical research
    Breast cancer (Dove Medical Press)
    Breast Cancer Research and Treatment
    Breast Cancer: Targets and Therapy
    Breast Cancer: Basic and Clinical Research
    Breast Care
    The Breast
    Breast Cancer-Targets and Therapy